We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17.9%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.6B
AUM Growth
+$1.99B
Cap. Flow
-$290M
Cap. Flow %
-2.3%
Top 10 Hldgs %
21.14%
Holding
876
New
80
Increased
408
Reduced
263
Closed
68

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$146M
2
CRM icon
Salesforce
CRM
+$65.4M
3
MRK icon
Merck
MRK
+$57.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$50.8M
5
C icon
Citigroup
C
+$46.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.01%
2 Technology 22.68%
3 Consumer Discretionary 9.38%
4 Financials 7.85%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQNR icon
776
Equinor
EQNR
$97.3B
$1K ﹤0.01%
89
+7
+9% +$106
GSK icon
777
GSK
GSK
$107B
$1K ﹤0.01%
32
+18
+129% +$827
NVCR icon
778
NovoCure
NVCR
$1.76B
$1K ﹤0.01%
4
-6
-60% -$821
VOD icon
779
Vodafone
VOD
$37.1B
$1K ﹤0.01%
49
+8
+20% +$125
WBK
780
DELISTED
Westpac Banking Corporation
WBK
$1K ﹤0.01%
95
-90
-49% -$1.26K
BBL
781
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$1K ﹤0.01%
+23
New +$1.05K
ACN icon
782
Accenture
ACN
$106B
-7
Closed -$2K
ADCT icon
783
ADC Therapeutics
ADCT
$140M
$0 ﹤0.01%
+9
New +$295
AKBA icon
784
Akebia Therapeutics
AKBA
$338M
-70,000
Closed -$176K
ALLO icon
785
Allogene Therapeutics
ALLO
$625M
-66,561
Closed -$2.51M
AMRN
786
Amarin Corp
AMRN
$297M
-30,300
Closed -$2.55M
AVDL
787
DELISTED
Avadel Pharmaceuticals
AVDL
-85,000
Closed -$428K
AZTA icon
788
Azenta
AZTA
$1.3B
-270,525
Closed -$12.5M
BLFS icon
789
BioLife Solutions
BLFS
$1.54B
-45,000
Closed -$1.3M
BMI icon
790
Badger Meter
BMI
$3.87B
-16,920
Closed -$1.11M
BSBR icon
791
Santander
BSBR
$38.2B
-12,444
Closed -$59K
CDNA icon
792
CareDx
CDNA
$1.83B
-40,000
Closed -$1.52M
CHGG icon
793
Chegg
CHGG
$116M
-3,100
Closed -$221K
CHKP icon
794
Check Point Software Technologies
CHKP
$14.3B
-4
Closed
CNX icon
795
CNX Resources
CNX
$4.91B
-485,285
Closed -$4.58M
CRSP icon
796
CRISPR Therapeutics
CRSP
$4.69B
$0 ﹤0.01%
+3
New +$355
ESPR
797
DELISTED
Esperion Therapeutics
ESPR
-95,955
Closed -$3.57M
FRT icon
798
Federal Realty Investment Trust
FRT
$10.9B
-3,647
Closed -$268K
GGAL icon
799
Galicia Financial Group
GGAL
$7.89B
-146,000
Closed -$1.06M
HMC icon
800
Honda
HMC
$39.8B
-115
Closed -$3K

Similar funds

Candriam SCA's Q4 2020 Portfolio in Review

As of Q4 2020, Candriam SCA held 876 positions worth $12.6B, up 19% from $10.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q4 2020 filing shows 80 new, 408 increased, 263 reduced and 68 closed positions. Its largest new stake was Salesforce: 269,070 shares worth $59.9M. The largest sale was Amazon, an estimated $76.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q4 2020 buy was Salesforce: 269,070 shares worth $59.9M.
  • Candriam SCA added most to Apple in Q4 2020, an estimated $146M increase.
  • Candriam SCA's biggest Q4 2020 reduction was Amazon, cutting an estimated $76.3M.
  • Candriam SCA fully exited VIVINT SOLAR, INC. in Q4 2020, selling an estimated $35.6M.
  • Candriam SCA's ten largest holdings make up 21% of its $12.6B portfolio in Q4 2020.
  • Candriam SCA opened 80 new positions and closed 68 in Q4 2020.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $12.6B.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.